<DOC>
	<DOCNO>NCT01364987</DOCNO>
	<brief_summary>This study characterize pharmacokinetic effect ASP015K mycophenolate mofetil healthy volunteer .</brief_summary>
	<brief_title>Pharmacokinetic Interaction Study Assess Effect ASP015K Mycophenolate Mofetil Healthy Volunteers</brief_title>
	<detailed_description>The subject confine unit 13 day brief follow-up visit obtain hematology blood sample . Numerous blood urine sample take determine pharmacokinetics drug .</detailed_description>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>If female , subject least 2 year post menopausal surgically sterile per documentation provide third party medical professional subject pregnant document negative serum pregnancy test If male , subject agree sexual abstinence and/or use highly effective method birth control study period Subject medically healthy , clinically significant medical history abnormality Subjects must weigh least 45 kg body mass index ( BMI ) 1832 kg/m2 Subject history chronic diarrhea Subject vaccinate within last 60 day prior study drug administration The subject previous history clinically significant neurological , gastrointestinal , renal , hepatic , pulmonary , metabolic , cardiovascular , psychiatric , endocrine , hematological disorder disease Subject positive test hepatitis C antibody , positive hepatitis B surface antigen ( HBsAg ) Subject history human immunodeficiency virus ( HIV ) antibody The subject absolute neutrophil count ( ANC ) &lt; 2500 cells/mm3 Subject clinically significant illness within 1 month prior study drug administration Subject recent history ( within last 6 month ) drug alcohol abuse positive urine screen alcohol drug abuse/illegal drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>transplant</keyword>
	<keyword>ASP015K</keyword>
	<keyword>healthy subject</keyword>
</DOC>